Announced Fri, 10 Jul · 16:37 IST
RTA certificate under SEBI regulation 74(5) for Q1 FY27 filed
Compliance View source PDF
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.3%1-day move
₹271.85
prior close
₹270.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.9-0.6-0.6-0.3+1.6+1.1-2.0-2.0-10.9————
Up moveDown movePending
AI summary
Marksans Pharma has submitted to BSE and NSE the quarterly certificate from its Registrar and Transfer Agent, Bigshare Services, under SEBI regulation 74(5) for the quarter ended 30 June 2026. The certificate confirms that no dematerialisation requests for the companys equity shares were received between 1 April 2026 and 30 June 2026. The filing was signed by Company Secretary Harshavardhan Panigrahi on 10 July 2026.
Likely market impact
Routine procedural compliance filing with no material effect on shareholders or stock price.